Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease

Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases

Joël Mossong, Niel Hens, Mark Jit et al. · PLoS Medicine · 2008 · 3.2K citations · Full text

Veterinary Medicine, Infectious Diseases, Population Health Sciences +15

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial

Stéphane Verguet, Jane J. Kim, Dean T. Jamison · PharmacoEconomics · 2016 · 257 citations · Full text

Public Affairs, Health Policy, Public Policy +17

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England

Shamez Ladhani, Nick Andrews, Sydel R. Parikh et al. · New England Journal of Medicine · 2020 · 208 citations · Full text

Medicine, Infectious Diseases, Pediatrics +16

Outcomes of invasive meningococcal serogroup B disease in children and adolescents (MOSAIC): a case-control study

Russell Viner, Robert Booy, Helen Johnson et al. · The Lancet Neurology · 2012 · 198 citations

Medicine, Infectious Diseases, Pediatrics +11

Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia

Helen Marshall, Mark McMillan, Ann P. Koehler et al. · New England Journal of Medicine · 2020 · 184 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17